Reduced-Antigen, Combined Diphtheria-Tetanus-Acellular Pertussis Vaccine, Adsorbed (Boostrix® US Formulation) Use as a Single-Dose Booster Immunization in …
JE Frampton, SJ Keam - Pediatric Drugs, 2006 - Springer
Abstract▲ Boostrix® US formulation (hereafter referred to as Tdap) is a formulation of
reduced-antigen, combined diphtheria-tetanus-acellular pertussis vaccine, adsorbed onto …
reduced-antigen, combined diphtheria-tetanus-acellular pertussis vaccine, adsorbed onto …
Reduced-antigen combined diphtheria-tetanus-acellular pertussis vaccine (Boostrix™)
TM Chapman, KL Goa - Drugs, 2003 - Springer
Abstract▴ The reduced-antigen combined diphtheria-tetanus-acellular pertussis vaccine
(dTpa) is intended for use as a booster dose in individuals aged≥ 4 years.▴ A single dose …
(dTpa) is intended for use as a booster dose in individuals aged≥ 4 years.▴ A single dose …
Reduced-Antigen, Combined Diphtheria, Tetanus, and Acellular Pertussis Vaccine, Adsorbed (Boostrix®) A Guide to Its Use as a Single-Dose Booster Immunization …
LJ Scott, PL McCormack - BioDrugs, 2013 - Springer
Reduced-antigen, combined diphtheria, tetanus, and three-component acellular pertussis
vaccine (Tdap; Boostrix®) is indicated for booster vaccination against diphtheria, tetanus …
vaccine (Tdap; Boostrix®) is indicated for booster vaccination against diphtheria, tetanus …
Reduced-Antigen, Combined Diphtheria, Tetanus and Acellular Pertussis Vaccine, Adsorbed (Boostrix®) A Review of its Properties and Use as a Single-Dose Booster …
PL McCormack - Drugs, 2012 - Springer
Reduced-antigen, combined diphtheria, tetanus and three-component acellular pertussis
vaccine (Tdap; Boostrix®) is indicated for booster vaccination against diphtheria, tetanus …
vaccine (Tdap; Boostrix®) is indicated for booster vaccination against diphtheria, tetanus …
Reduced-Antigen, Combined Diphtheria, Tetanus, and Acellular Pertussis Vaccine (Boostrix™) A Review of its Use as a Single-Dose Booster Immunization
JE Frampton, GM Keating - BioDrugs, 2006 - Springer
Reduced-antigen, combined diphtheria, tetanus, and acellular pertactin-containing pertussis
vaccine (dTpa; Boostrix™) contains reduced quantities of the same toxoids/antigens found …
vaccine (dTpa; Boostrix™) contains reduced quantities of the same toxoids/antigens found …
Evaluation of a new syringe presentation of reduced-antigen content diphtheria, tetanus, and acellular pertussis vaccine in healthy adolescents-A single blind …
N Pavia-Ruz, K Abarca, A Lepetic… - Human Vaccines & …, 2015 - Taylor & Francis
Reduced-antigen-content diphtheria-tetanus-acellular pertussis (dTpa) vaccine, Boostrix™,
is indicated for booster vaccination of children, adolescents and adults. The original prefilled …
is indicated for booster vaccination of children, adolescents and adults. The original prefilled …
Combined, Reduced-Antigen Content Tetanus, Diphtheria, and Acellular Pertussis Vaccine (Boostrix®) A Review of its Use as a Single-Dose Booster Immunization in …
GL Plosker - BioDrugs, 2009 - Springer
Boostrix® is a three-pertussis component, combined, reduced-antigen content tetanus,
diphtheria, and acellular pertussis (Tdap) booster vaccine administered as a single …
diphtheria, and acellular pertussis (Tdap) booster vaccine administered as a single …
Booster vaccination against pertussis in Chinese children at six years of age using reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (Boostrix™ …
F Zhu, S Zhang, Q Hou, Y Zhang, Y Xu, X Ma… - Human …, 2010 - Taylor & Francis
Pertussis continues to circulate in Chinese communities and older children, adolescents and
adults are sources of infection for unprotected infants. Two studies conducted in Jiangsu …
adults are sources of infection for unprotected infants. Two studies conducted in Jiangsu …
Phase 1 trial of an investigational Tdap booster vaccine with CpG 1018 adjuvant compared with Boostrix in healthy adults and adolescents
P Richmond, T Nolan, A McGirr, F Napier-Flood, J Kim… - Vaccine, 2024 - Elsevier
This phase 1 trial assessed the safety and immunogenicity of an investigational
tetanus/diphtheria/acellular pertussis vaccine combined with CpG 1018 adjuvant 1500 μg …
tetanus/diphtheria/acellular pertussis vaccine combined with CpG 1018 adjuvant 1500 μg …
Reactogenicity and immunogenicity of reduced antigen content diphtheria–tetanus–acellular pertussis vaccines as a booster in 4–7-year-old children primed with …
R Dagan, K Igbaria, L Piglansky, F Van Brusteghem… - Vaccine, 1999 - Elsevier
Background. The recent introduction of acellular pertussis vaccines (Pa) offers the possibility
of booster doses in older children and adults. This can be conveniently accomplished by …
of booster doses in older children and adults. This can be conveniently accomplished by …